Ceftazidime/avibactam as a possible treatment option for carbapenem-resistant Enterobacterales infections
Carbapenem resistance (CR) in Enterobacterales is frequently determined by the production of enzymes, so called carbapenemases, (KPC, NDM, OXA-48 etc) or by porin deficiencies, combined with ESBLs. Several new agents with activity against certain carbapenemresistant pathogens have been approved for...
Saved in:
| Main Authors: | Ana Kaftandzieva, Gordana Mirchevska |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
University Ss Cyril and Methodius in Skopje, Faculty of Pharmacy and Macedonian Pharmaceutical Association
2025-12-01
|
| Series: | Makedonsko Farmacevtski Bilten |
| Subjects: | |
| Online Access: | http://bulletin.mfd.org.mk/volumes/Volume%2071_2/71_2_004.pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Comparison of meropenem-vaborbactam with ceftazidime-avibactam in the treatment of carbapenem-resistant Enterobacterales infections
by: Luca Mezzadri, et al.
Published: (2024-12-01) -
Safety and Efficacy of Ceftazidime/Avibactam in the Treatment of Severe Neonatal Infections
by: Mi Zhou, et al.
Published: (2024-12-01) -
Assessment of in vitro activity of ceftazidime/avibactam on carbapenemase‐producing Enterobacterales from Iran: An experimental study
by: Mehri Haeili, et al.
Published: (2024-08-01) -
Risk factors for mortality in patients treated with ceftazidime-avibactam for ceftazidime-avibactam susceptible carbapenem-resistant Klebsiella pneumoniae bacteremia
by: Yi-Tsung Lin, et al.
Published: (2025-09-01) -
Impact of ceftazidime avibactam on colonization by carbapenem resistant Enterobacterales during treatment of related infections
by: Uğur Önal, et al.
Published: (2025-08-01)